| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |